liu.seSearch for publications in DiVA
Change search
ReferencesLink to record
Permanent link

Direct link
Clinical trial: colectomy after rescue therapy in ulcerative colitis-3-year follow-up of the Swedish-Danish controlled infliximab study
Örebro University Hospital, Sweden.
Örebro University Hospital, Sweden.
Lund University Hospital, Sweden.
Sahlgrenska University Hospital, Göteborg, Sweden.
Show others and affiliations
2010 (English)In: Alimentary Pharmacology and Therapeutics, ISSN 0269-2813, E-ISSN 1365-2036, Vol. 32, no 8, 984-989 p.Article in journal (Refereed) Published
Abstract [en]

Background The long-term efficacy of infliximab as rescue therapy in steroid-refractory ulcerative colitis is not well described.

Aim To examine the long-term efficacy of infliximab as a rescue therapy through a 3-year follow-up of a previous placebo-controlled trial of infliximab in acute steroid-refractory ulcerative colitis.

Method In the original study, 45 patients were randomized to a single infusion of infliximab 5 mg/kg or placebo, and at 3 months, 7/24 patients given infliximab were operated vs. 14/21 patients given placebo. Three years or later, patients were asked to participate in a clinical follow-up.

Results Another seven patients underwent colectomy during follow-up: five in the infliximab group and two in the placebo group. After 3 years, a total of 12/24 (50%) patients given infliximab and 16/21 (76%) given placebo (P = 0.012) had a colectomy. None of eight patients in endoscopic remission at 3 months later had a colectomy compared with 7/14 (50%) patients who were not in remission (P = 0.02). There was no mortality.

Conclusion The benefit of rescue therapy with infliximab in steroid-refractory acute ulcerative colitis remained after 3 years. The main advantage of infliximab treatment occurred during the first 3 months, whereas subsequent colectomy rates were similar in the two groups. Mucosal healing at 3 months influenced later risk of colectomy.

Place, publisher, year, edition, pages
Blackwell Publishing Ltd , 2010. Vol. 32, no 8, 984-989 p.
National Category
Medical and Health Sciences
URN: urn:nbn:se:liu:diva-60515DOI: 10.1111/j.1365-2036.2010.04435.xISI: 000282221200004OAI: diva2:357039
Available from: 2010-10-15 Created: 2010-10-15 Last updated: 2011-01-19

Open Access in DiVA

No full text

Other links

Publisher's full text

Search in DiVA

By author/editor
Gustavsson, AJärnerot, GHertervig, EFriis-Liby, IBlomquist, LKarlén, PVilien, MStröm, MagnusVerbaan, HHellström, P MMagnuson, AHalfvarson, JTysk, C
By organisation
Gastroenterology and HepatologyFaculty of Health SciencesDepartment of Endocrinology and Gastroenterology UHL
In the same journal
Alimentary Pharmacology and Therapeutics
Medical and Health Sciences

Search outside of DiVA

GoogleGoogle Scholar
The number of downloads is the sum of all downloads of full texts. It may include eg previous versions that are now no longer available

Altmetric score

Total: 21 hits
ReferencesLink to record
Permanent link

Direct link